PMA device
Master InterStim® Therapy System, Verify® Evaluation System
Medtronic Neuromodulation · Stimulator, Electrical, Implantable, For Incontinence (EZW, Class III) · First FDA decision Sep 25, 2017, newest Feb 22, 2022Fecal incontinence and constipationOveractive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Master InterStim Therapy"
MAUDE reports
0
Brand "Master InterStim Therapy", since 2015
PubMed studies
0
Mentioning "Master InterStim Therapy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Master InterStim® Therapy System, Verify® Evaluation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 3 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Master InterStim Therapy", any status and sponsor, newest update first.
No registered device study names "Master InterStim Therapy".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Master InterStim Therapy", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code EZW
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Master InterStim Therapy"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code EZW.
- InterStim Therapy System, Verify Evaluation SystemMedtronic Neuromodulation · PMA 2025
- Axonics Sacral Neuromodulation SystemBoston Scientific Corporation · PMA 2026
- InterStim® Sacral Nerve Stimulation Therapy System (Urinary Control )Medtronic Neuromodulation · PMA 2018
- Neuspera Sacral Neuromodulation (SNM) SystemNeuspera Medical, Inc. · PMA 2026
- Interstim SystemMedtronic Neuromodulation · PMA 2011
- Medtronic Interstim Tined Lead Models 3889 & 3093Medtronic Neuromodulation · PMA 2007
- Virtis Sacral Neuromodulation SystemCirtec Medical Corporation · PMA 2023
- Verify Evaluation System for Interstim Therapy for Urinary Control and Bowel ControlMedtronic Neuromodulation · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.